Ars Pharmaceuticals Inc (SPRY)

Ars Pharmaceuticals Inc Stock (SPRY) Financials Data

*All numbers in millions

Period End Date	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	12.04%37.71	33.66	22.68	28.09	32.50
	24.43%71.88	95.12	82.83	69.55	85.69
Selling, General, and Administrative	43.90%43.52	77.58	72.20	59.96	74.75
Research and Development	288.74%18.26	4.70	4.34	3.44	2.75
Depreciation and Amortization	0.24%0.42	0.42	0.40	0.42	0.39
Operating Income/Loss	44.41%-34.17	-61.47	-60.15	-41.47	-53.19
	42.91%-35.59	-62.34	-60.62	-41.32	-51.15
Attributable To Parent	42.91%-35.59	-62.34	-60.62	-41.32	-51.15
Basic Average Shares	0.38%99.69	99.31	99.30	0.15	98.81
Diluted Average Shares	0.38%99.69	99.31	99.30	0.15	98.81
Basic Earnings Per Share	42.86%-0.36	-0.63	-0.61	-0.42	-0.52
Diluted Earnings Per Share	42.86%-0.36	-0.63	-0.61	-0.42	-0.52